PEY15 LATANOPROST VERSUS TIMOLOL MONOTHERAPY FOR THE TREATMENT OF GLAUCOMA-A COST-EFFECTIVNESS ANALYSIS IN SCANDINAVIA AND THE UK USING A DECISION-ANALYTIC HEALTH ECONOMIC MODEL
Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63721-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)63721-7/fulltext
Section Title :
Section Order :
573
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63721-7&doi=10.1016/S1098-3015(10)63721-7